Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Accepts DTC Limits In Deal With States

May 20 2008

• By Brenda Sandburg

Related Content

Merck Delayed Reporting Vioxx Mortality Risk in Alzheimer’s Patients – JAMA Article

Apr 15 2008

Merck’s $4.85 Billion Vioxx Settlement Could Set Industry Standard To Resolve Litigation

Nov 09 2007

Merck Pays $650 Million To Settle Medicaid Pricing, Marketing Charges

Feb 07 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window